Post-COVID Postural Orthostatic Tachycardia Syndrome Postural Orthostatic Tachycardia Syndrome
Infectious Diseases
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
argenxEfgartigimod
Clinical Trials (1)
Total enrollment: 33 patients across 1 trials
Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS
Start: Jun 2023Est. completion: Aug 202433 patients
Phase 2Terminated
Related Jobs in Infectious Diseases
Senior Recruiter
Invivyd
New Haven, CT (Northeast preferred)
7h ago
$120K - $160K/yr
Senior Associate Scientist (contract), Upstream Polysaccharide Process Development
VaxCyte
San Carlos, California, United States
9h ago
$56/hr
Senior Associate Scientist (contract), Polysaccharide Analytical Development
VaxCyte
San Carlos, California, United States
9h ago
$56/hr
Director, Program Management
Metaphore Biotechnologies
Somerville, MA USA
13h ago
$179K - $237K/yr
Technician, Operations, DSP/ Technicien(ne) des opérations, DSP
Verona Pharma
CAN - Prince Edward Island - Charlottetown
Yesterday
$47K - $79K/yr
HVAC Maintenance Technician
Verona Pharma
USA - Delaware - Millsboro (Intervet)
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space